ifosfamide has been researched along with Small Cell Lung Carcinoma in 11 studies
Small Cell Lung Carcinoma: A form of highly malignant lung cancer that is composed of small ovoid cells (SMALL CELL CARCINOMA).
| Excerpt | Relevance | Reference |
|---|---|---|
| " This phase II study evaluated the efficacy and safety of IFM combination with recommended current supportive therapy for recurrent SCLC in second-line and heavily treated setting." | 2.87 | A phase II trial of Ifosfamide combination with recommended supportive therapy for recurrent SCLC in second-line and heavily treated setting. ( Fukatsu, A; Hase, T; Hasegawa, Y; Hayashi, H; Kawada, K; Kondo, M; Morise, M; Nomura, F; Sokai, A; Tanaka, I, 2018) |
| "To investigate the prognostic value of systemic exposure to etoposide (Area Under the concentration Curve (AUC(VP16))) on overall survival (OS) in patients with small cell lung cancer (SCLC)." | 2.73 | Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study. ( Chabaud, S; Court-Fortune, I; Falandry, C; Fournel, C; Freyer, G; Girard, P; Ribba, B; Souquet, PJ; Tod, M; Tranchand, B; Trillet-Lenoir, V; You, B, 2008) |
| " No significant dose-response relationship was found in terms of LRC." | 1.37 | Sequential or concomitant chemotherapy in limited stage small-cell lung cancer. ( Anchisi, S; Bieri, S; Elhfidh, M; Khanfir, K; Matzinger, O; Mirimanoff, RO; Ozsahin, M; Zouhair, A, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Miyoshi, AI | 1 |
| Ueda, Y | 1 |
| Kurita, T | 1 |
| Kimura, T | 1 |
| Yoshino, K | 1 |
| Tanaka, I | 1 |
| Kawada, K | 1 |
| Morise, M | 1 |
| Hase, T | 1 |
| Hayashi, H | 1 |
| Sokai, A | 1 |
| Fukatsu, A | 1 |
| Kondo, M | 1 |
| Nomura, F | 1 |
| Hasegawa, Y | 1 |
| Boni, C | 1 |
| Pagano, M | 1 |
| Baldi, L | 1 |
| Gnoni, R | 1 |
| Braglia, L | 1 |
| Savoldi, L | 1 |
| Zanelli, F | 1 |
| Girard, N | 1 |
| Cottin, V | 1 |
| Lapalus, MG | 1 |
| Tronc, F | 1 |
| Cordier, JF | 1 |
| Bregni, M | 1 |
| Pedrazzoli, P | 1 |
| Némati, F | 1 |
| Daniel, C | 1 |
| Arvelo, F | 1 |
| Legrier, ME | 1 |
| Froget, B | 1 |
| Livartowski, A | 1 |
| Assayag, F | 1 |
| Bourgeois, Y | 1 |
| Poupon, MF | 1 |
| Decaudin, D | 1 |
| Khanfir, K | 1 |
| Elhfidh, M | 1 |
| Anchisi, S | 1 |
| Matzinger, O | 1 |
| Bieri, S | 1 |
| Mirimanoff, RO | 1 |
| Ozsahin, M | 1 |
| Zouhair, A | 1 |
| Abedallaa, N | 1 |
| Tremblay, L | 1 |
| Baey, C | 1 |
| Fabre, D | 1 |
| Planchard, D | 1 |
| Pignon, JP | 1 |
| Guigay, J | 1 |
| Pechoux, CL | 1 |
| Soria, JC | 1 |
| de Montpreville, VT | 1 |
| Besse, B | 1 |
| Luo, J | 1 |
| Wu, FY | 1 |
| Li, AW | 1 |
| Zheng, D | 1 |
| Liu, JM | 1 |
| Su, Y | 1 |
| You, B | 1 |
| Tranchand, B | 1 |
| Girard, P | 1 |
| Falandry, C | 1 |
| Ribba, B | 1 |
| Chabaud, S | 1 |
| Souquet, PJ | 1 |
| Court-Fortune, I | 1 |
| Trillet-Lenoir, V | 1 |
| Fournel, C | 1 |
| Tod, M | 1 |
| Freyer, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| PEI REGIMEN: A THERAPEUTIC OPTION IN SMALL CELL LUNG CANCER? A MONOINSTITUTIONAL EXPERIENCE OF 46 CONSECUTIVE CASES[NCT02324296] | 46 participants (Actual) | Observational | 1998-12-31 | Completed | |||
| A Phase Ⅱ Single-arm Clinical Trial to Investigate the Efficacy and Safety of Vinorelbine-ifosfamide Regimen as Third-line Treatment in Refractory or Recurrent Extensive Small Cell Lung Cancer Patients[NCT01752517] | 60 participants (Anticipated) | Observational | 2012-12-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for ifosfamide and Small Cell Lung Carcinoma
| Article | Year |
|---|---|
Recent Advances in the Management of Small Cell Carcinoma of the Uterine Cervix.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Ce | 2023 |
2 trials available for ifosfamide and Small Cell Lung Carcinoma
| Article | Year |
|---|---|
A phase II trial of Ifosfamide combination with recommended supportive therapy for recurrent SCLC in second-line and heavily treated setting.
Topics: Aged; Amylases; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; E | 2018 |
Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Ca | 2008 |
8 other studies available for ifosfamide and Small Cell Lung Carcinoma
| Article | Year |
|---|---|
Pei regimen: a therapeutic option in small cell lung cancer? A retrospective monoinstitutional analysis of 46 consecutive cases.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Etoposide; Fem | 2015 |
Synchronous small-cell lung cancer and gastrointestinal stromal tumor: a case report.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplasti | 2009 |
Re: 'A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small-cell lung cancer: a randomized trial'.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemot | 2009 |
Clinical relevance of human cancer xenografts as a tool for preclinical assessment: example of in-vivo evaluation of topotecan-based chemotherapy in a panel of human small-cell lung cancer xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Resistance, Neoplasm; Etopo | 2010 |
Sequential or concomitant chemotherapy in limited stage small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modali | 2011 |
Effect of chemotherapy in patients with resected small-cell or large-cell neuroendocrine carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuro | 2012 |
Comparison of vinorelbine, ifosfamide and cisplatin (NIP) and etoposide and cisplatin (EP) for treatment of advanced combined small cell lung cancer (cSCLC) patients: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; | 2012 |
[Efficacy of adriamycin, etoposide plus ifosfamide on small cell lung cancer--a retrospective analysis of 69 cases treated in Centre Hospitalo-Universitaire de Bordeaux].
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubi | 2006 |